The SDHD:p.H102R Variant Is Frequent in Russian Patients with Head and Neck Paragangliomas and Associated with Loss of 11p15.5 Region and Hypermethylation of H19-DMR
-
Published:2022-12-30
Issue:1
Volume:24
Page:628
-
ISSN:1422-0067
-
Container-title:International Journal of Molecular Sciences
-
language:en
-
Short-container-title:IJMS
Author:
Snezhkina AnastasiyaORCID, Fedorova MariaORCID, Kobelyatskaya Anastasiya, Markova Daria, Lantsova Margarita, Ikonnikova AnnaORCID, Emelyanova Marina, Kalinin DmitryORCID, Pudova Elena, Melnikova NataliyaORCID, Dmitriev AlexeyORCID, Krasnov GeorgeORCID, Pavlov VladislavORCID, Kudryavtseva AnnaORCID
Abstract
Head and neck paragangliomas (HNPGLs) are rare neuroendocrine neoplasms derived from the parasympathetic paraganglia of the head and neck. At least 30% of HNPGLs are linked to germline mutations, predominantly in SDHx genes. In this study, we analyzed an extended cohort of Russian patients with HNPGLs using whole-exome sequencing and found a highly frequent missense variant p.H102R in the SDHD gene. We determined this variant in 34% of the SDHD mutation carriers. This variant was associated with somatic loss of the gene wild-type allele. Data from the B allele frequency method and microsatellite and microdeletion analysis indicated evident LOH at the 11p15.5 region and potential loss of the whole of chromosome 11. We found hypermethylation of H19-DMR in all tumors, whereas differential methylation of KvDMR was mostly retained. These findings do not support the paternal transmission of SDHD:p.H102R but are in agreement with the Hensen model. Using targeted sequencing, we also studied the variant frequency in a control cohort; we found SDHD:p.H102R in 1.9% of cases, allowing us to classify this variant as pathogenic. The immunohistochemistry of SDHB showed that the SDHD:p.H102R mutation, even in combination with wild-type allele loss, does not always lead to SDH deficiency. The obtained results demonstrate the frequent variant associated with HNPGLs in a Russian population and support its pathogenicity. Our findings help with understanding the mechanism of tumorigenesis and are also important for the development of cost-effective genetic screening programs.
Funder
Russian Science Foundation
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference44 articles.
1. Lloyd, R., Osamura, R., Klöppel, G., and Rosai, J. (2017). WHO Classification of Tumours of Endocrine Organs. 2. El-Naggar, A.K., Chan, J.K.C., Rubin Grandis, J., Takata, T., Slootweg, P.J., and International Agency for Research on C (2017). WHO Classification of Head and Neck Tumours. 3. Snezhkina, A., Pavlov, V., Dmitriev, A., Melnikova, N., and Kudryavtseva, A. (2021). Potential Biomarkers of Metastasizing Paragangliomas and Pheochromocytomas. Life, 11. 4. 15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1-5;Benn;Endocr. Relat. Cancer,2015 5. Mitochondrial complex II and genomic imprinting in inheritance of paraganglioma tumors;Baysal;Biochim. Biophys. Acta,2013
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|